EyePoint Pharmaceuticals
EYPT
EYPT
41 hedge funds and large institutions have $29.1M invested in EyePoint Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
Holders
41
Holding in Top 10
–
Calls
$882K
Puts
$83K
Top Buyers
| 1 | +$58K | |
| 2 | +$47.9K | |
| 3 | +$36.4K | |
| 4 |
Renaissance Technologies
New York
|
+$34.2K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$31K |
Top Sellers
| 1 | -$4.86M | |
| 2 | -$482K | |
| 3 | -$280K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$149K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$101K |